This compound is a salt form of a statin-related molecule, consisting of a chiral heptenoic acid derivative combined with (1R)-1-phenylethanamine. It is primarily used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 147511-70-4
N-(4-Methylbenzene-1-sulfonyl)-N-(prop-2-en-1-yl)benzenecarbohydrazonic acid
pharmaceutical raw material
1-Boc-4-Methylaminopiperidine
pharmaceutical intermediate
Alcaftadine Methylhydroxy-N-demethylated
pharmaceutical intermediate
5-Chloro-1,2-dihydro-4-methoxy-2-oxo-3-pyridinecarbonitrile
pharmaceutical intermediate
Trans-4'-(3,4-Difluorophenyl)-[1,1'-bicyclohexyl]-4-one
pharmaceutical intermediate
Pitavastatin calcium
pharmaceutical raw material
Pitavastatin sodium
pharmaceutical raw material
(Z)-Pitavastatin calcium
pharmaceutical raw material
(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid;(1R)-1-phenylethanamine
NWJUCTSWJKMGJX-FLBGKGFLSA-N
C[C@H](C1=CC=CC=C1)N.C1CC1C2=NC3=CC=CC=C3C(=C2/C=C/[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F
—